You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API natamycin

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing natamycin

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Alcon Laboratories Inc	NATACYN	natamycin	0065-0645	BENZALKONIUM CHLORIDE
Alcon Laboratories Inc	NATACYN	natamycin	0065-0645	HYDROCHLORIC ACID
Alcon Laboratories Inc	NATACYN	natamycin	0065-0645	SODIUM HYDROXIDE
Alcon Laboratories Inc	NATACYN	natamycin	0065-0645	WATER
Eyevance Pharmaceuticals LLC	NATACYN	natamycin	71776-005	BENZALKONIUM CHLORIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for natamycin

Excipient focus: BENZALKONIUM CHLORIDE

natamycin drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Alcon Laboratories Inc	natamycin	0065-0645
Eyevance Pharmaceuticals LLC	natamycin	71776-005
Harrow Eye LLC	natamycin	82667-012
>Company	>Ingredient	>NDC

natamycin drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

natamycin drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Alcon Laboratories Inc	natamycin	0065-0645
Eyevance Pharmaceuticals LLC	natamycin	71776-005
Harrow Eye LLC	natamycin	82667-012
>Company	>Ingredient	>NDC

natamycin drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

natamycin drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Alcon Laboratories Inc	natamycin	0065-0645
Eyevance Pharmaceuticals LLC	natamycin	71776-005
Harrow Eye LLC	natamycin	82667-012
>Company	>Ingredient	>NDC

natamycin drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

natamycin drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Alcon Laboratories Inc	natamycin	0065-0645
Eyevance Pharmaceuticals LLC	natamycin	71776-005
Harrow Eye LLC	natamycin	82667-012
>Company	>Ingredient	>NDC

natamycin drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.